Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | FABP4 | P15090 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4554766 | 0.88 | NOTUM (0.36) | CYP1A2CYP2C9CYP2C19NPC1ALDH1A1 | |
| SCHEMBL963202 | 0.88 | CYP1A2 (0.38) | CYP1A2CYP2C9CYP2C19FABP4NPC1 | |
| SCHEMBL962156 | 0.84 | ALDH1A1 (0.48) | FABP4NPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL962154 | 0.84 | ALDH1A1 (0.48) | FABP4NPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL4553928 | 0.83 | CA12 (0.35) | CYP1A2CYP2C9CYP2C19NPC1ALDH1A1 | |
| SCHEMBL967577 | 0.76 | CYP1A2 (0.42) | CYP1A2CYP2C9CYP2C19ALDH1A1SMN1; SMN2 | |
| SCHEMBL4554436 | 0.75 | MAPT (0.42) | — | |
| SCHEMBL4554187 | 0.75 | HTR2A (0.33) | HTR2AHTR2C | |
| SCHEMBL4554908 | 0.74 | CDC7 (0.37) | HTR2AHTR2C | |
| SCHEMBL4553594 | 0.74 | KDM4E (0.35) | ALDH1A1HTR2AHTR2CHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2118066-A1 | FUSED RING COMPOUNDS AS PARTIAL AGONISTS OF PPAR-GAMMA | Takeda Pharmaceutical Company Limited (JP) | 2009-11-18 | — | — | EP | disclosed |
| WO-2008099794-A1 | FUSED RING COMPOUNDS AS PARTIAL AGONISTS OF PPAR-GAMMA | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-08-21 | — | — | WO | disclosed |